Company / Tangible Book Value per Share
Dyne Therapeutics, Inc. Tangible Book Value per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.16
FY2024
5-year range
$1.49 / $23.78
FY2020-FY2024
Trend
+314.5%
vs FY2023
Sector context
#90 of 211
Health Care
What the data says
Tangible Book Value per Share changed +314% YoY in FY2024, a notable deviation from the 5-year average annual change of +91%.
Based on SEC 10-K filings.
6.16 in FY2024 with a 5-year CAGR of +1.4%.
Improved from $4.54 to $6.16 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -5.2%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
#90 of 211 in Health CareTop 43% of 211This company $6.16 Sector average $118.77
▼
-94.8% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share increased 314.5% year-over-year.
- Ranks #90 out of 211 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.16 | +314.5% |
| FY2023 | $1.49 | -67.3% |
| FY2022 | $4.54 | -37.3% |
| FY2021 | $7.23 | -69.6% |
| FY2020 | $23.78 | +313.9% |
| FY2019 | $5.75 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026